WHO is bringing the world’s scientists and global health professionals together to accelerate the research and development process, and develop new norms and standards to contain the spread of the coronavirus pandemic and help care for those affected. The R&D Blueprint has been activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus. The solidarity of all countrie
1 Advice on the use of masks the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak Interim guidance 29 January 2020 WHO/nCov/IPC_Masks/2020.1 Introduction This document provides rapid advice on the use of medical masks in communities, at home and at health care facilities in areas that have reported outbreaks caused by the 2019 nov
The current COVID-19 pandemic is unprecedented, but the global response draws on the lessons learned from other disease outbreaks over the past several decades. As part of WHO’s response, the R&D Blueprint was activated to accelerate diagnostics, vaccines and therapeutics for this novel coronavirus. The Blueprint aims to improve coordination between scientists and global health professionals, acce
Coronavirus disease (COVID-19) Epidemiological Updates and Monthly Operational Updates The Epidemiological Update provides an overview of the global, regional and country-level COVID-19 cases and deaths, highlighting key data and trends; as well as other pertinent epidemiological information concerning the COVID-19 pandemic. The COVID-19 Monthly Operational Update reports on WHO and partners’ acti
Statement on the first meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) The meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (IHR) (2005) regarding the outbreak of novel coronavirus 2019 in the People’s Republic of China, with exportations currently re
Making sense of health statistics Gerd Gigerenzer a a. Hardnig Center for Risk Literacy, Max Planck Institute for Human Development, Lentzeallee 94, 14195 Berlin, Germany. Correspondence to Gerd Gigerenzer (e-mail: [email protected]). Bulletin of the World Health Organization 2009;87:567-567. doi: 10.2471/BLT.09.069872 Many physicians, patients, health journalists and politicians do not understand
WHO today published its first ever list of antibiotic-resistant "priority pathogens" – a catalogue of 12 families of bacteria that pose the greatest threat to human health. The list was drawn up in a bid to guide and promote research and development (R&D) of new antibiotics, as part of WHO’s efforts to address growing global resistance to antimicrobial medicines. The list highlights in particular
We have developed a set of posters Depression: Let's talk for use in campaign activities and beyond. Each poster depicts a conversation between two people about depression: for example, a mother and daughter; a mother with her young baby and a health-care worker; a student and teacher; two men at work; and an older women with a younger woman. Posters are available in Arabic, Chinese, English, Fren
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
処理を実行中です
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く